Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Malaysia

Pharmaniaga Posts Disappointing Financial Results

February 2010 | Industry Trend Analysis

Malaysian drugmaker Pharmaniaga 'remains focused on strategies' despite releasing disappointing 2009 financial results. Sales and profit before tax both decreased compared with the previous year.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles
Pharmaniaga Acquires Errita Pharma

Industry / Malaysia BMI View: Pharmaniaga's acquisition of Errita Pharma has several benefits. Firstly, Errita Pharma will boost Pharmaniaga's access to Indonesia - one of the more populous and increasingly wealthy countries...
April 2013
Pharmaceutical And Healthcare Forecast Upgraded

Industry / Malaysia BMI View: Strong growth opportunities continue in Malaysia's pharmaceutical and healthcare sector, particularly in its generic drug market. This view is supported by the country's commitment to pharmaceuticals,...
January 2013
CCM Duopharma Sales Continue To Grow

Industry / Malaysia Despite a challenging operating environment, the leading generic drug manufacturer in Malaysia, CCM Duopharma, has released decent financial results. This development underlines BMI's view that pharmaceutical...
May 2009
Pharmaniaga Looks Abroad For Growth

Industry / Malaysia Malaysian drugmaker Pharmaniaga wants to increase overseas sales during 2008 to build on good financial results for the year ended December 21 2007. Last year, revenue grew by 11.7% to reach MYR1.18bn...
March 2008
Clinical Research Sector Expanding

Industry / Malaysia After seeing 70% average annual growth in Malaysia during recent years, US clinical research organisation (CRO) Quintiles has identified the country as a 'key' growth market. Accordingly the firm plans...
December 2007


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2013 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS